Tpg Financial Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Tpg Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$204.13 - $302.4 $21,841 - $32,356	107 Added 7.55%	1,524 $326,000
Q1 2022 Apr 14, 2022	BUY	$255.51 - $362.11 $81,507 - $115,513	319 Added 29.05%	1,417 $402,000
Q4 2021 Jan 14, 2022	BUY	$351.38 - $448.68 $54,815 - $69,994	156 Added 16.56%	1,098 $414,000
Q3 2021 Oct 08, 2021	BUY	$372.64 - $458.3 $61,485 - $75,619	165 Added 21.24%	942 $389,000
Q2 2021 Jul 13, 2021	BUY	$294.17 - $371.65 $24,121 - $30,475	82 Added 11.8%	777 $287,000
Q1 2021 Apr 16, 2021	BUY	$249.67 - $299.48 $173,520 - $208,138	695 New	695 $201,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tpg Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tpg Financial Advisors, LLC with notifications on news.